Burkholderia cepacia

Associated infections

• Bacteraemia, including intravascular catheter-associated infection
• Pneumonia and respiratory tract infection
• Chronic airway infection and cepacia syndrome in cystic fibrosis
• Urinary tract infection following instrumentation
• Surgical site and wound infection
• Peritonitis and exit-site infection in peritoneal dialysis patients

Transmission route

Healthcare-associated acquisition is typically indirect and vehicle-borne, arising from exposure to a contaminated aqueous product, solution or item of equipment rather than from person-to-person spread, although patient-to-patient transmission is recognised in cystic fibrosis populations. Immunocompromised patients, those with chronic lung disease and those with indwelling devices carry the greatest risk.

The characteristic pattern is a product-borne cluster. Because Bcc can survive and sometimes grow in dilute antiseptics, preservative-containing solutions and non-sterile aqueous preparations, a contaminated batch can distribute the organism widely across a facility or across multiple facilities, producing cases that appear epidemiologically unrelated until the common product is identified. Contamination may be intrinsic, introduced during manufacture, or extrinsic, introduced during use through topping up, decanting into reusable containers, dilution with non-sterile water, or prolonged use of an opened multi-use container. Outbreak investigations that stop at the ward and do not consider the possibility of a contaminated product will frequently fail to find the source. A distinguishing feature reported in several product-related outbreaks is polyclonality: recovery of multiple distinct Bcc strains from patients rather than a single clone points towards a common vehicle carrying a mixed population, and away from patient-to-patient spread.

Water systems are a secondary but real reservoir. Bcc survives in low-nutrient treated water, colonises tubing, storage vessels and fittings, and incorporates into mixed biofilm. Reduced chlorination of a hospital water system has been associated with a bacteraemia outbreak attributed to the organism, indicating that residual disinfectant in the supply exerts genuine control and that its loss can permit population expansion. In the reprocessing context the two pathways converge: water used to dilute a detergent or disinfectant, or to make up a working solution, is a route by which a water-system population reaches a chemical product, and a contaminated product is then applied throughout the workflow.

In dental practice, Bcc is relevant both as a waterline biofilm organism and through the aqueous products used at the chairside, including mouthwashes, which have been a documented outbreak vehicle. In CSD, the concern is contamination of detergent, lubricant and rinse-aid solutions and of the water used to prepare them.

Relevance in endoscopy and reprocessing

In relation to endoscope reprocessing, Burkholderia cepacia complex is best understood as a water- and solution-associated opportunist rather than an organism with a large published record of endoscope-mediated transmission. Its relevance is nevertheless real and follows from its behaviour in wet systems: it survives in low-nutrient water, colonises tubing and storage vessels, incorporates into biofilm, and tolerates concentrations of some biocides that are inhibitory to other Gram-negative organisms. These properties make it a credible persistent coloniser of water treatment and distribution equipment upstream of a washer-disinfector, and of the detergent or disinfectant solutions used within a reprocessing workflow.

The distinguishing feature of Bcc within a reprocessing department is that the chemistry itself can become the reservoir. Where the organism has been recovered, the investigation must extend beyond the water train to the in-use aqueous products: detergent and enzymatic cleaner containers, disinfectant reservoirs and dosing lines, lubricants and leak-test fluids, alcohol solutions that have been diluted, and any container that is topped up rather than fully emptied, cleaned and dried between fills. Reuse of spray bottles and dispensing containers without a validated decontamination step between refills is a recognised route by which a low-level population establishes in a product that is subsequently applied to every device processed.

Bcc is not a specifically named indicator organism in the AS 5369:2023 final rinse water criteria, which name Pseudomonas aeruginosa, Legionella species and environmental mycobacteria alongside a total viable count limit. This does not make its isolation from final rinse water benign. Because the final rinse follows high-level disinfection and is not subsequently disinfected, any organism present at that stage is deposited on a device declared patient-ready, and residual moisture retained in channels during storage permits further proliferation of an organism well adapted to nutrient-poor water. For CSD and dental facilities the concern is analogous: Bcc in a water system or in a made-up chemical solution indicates a wet-system control failure with a plausible route to patient-contacting fluid.

Interpreting a detection

Isolation of Burkholderia cepacia complex from a water or final rinse sample should be regarded as a genuine result rather than an artefact. Bcc is a true aqueous-environment organism, it is not a normal skin flora contaminant introduced during sampling, and it is not readily explained by ordinary handling error. It is, however, an organism whose identification is unreliable on phenotypic systems alone, so the first step is confirmation of the identification and retention of the isolate. Misidentification runs in both directions and an unconfirmed Bcc report should not by itself trigger a product recall or a supplier notification.

Once confirmed, the investigation should run along two parallel lines. The water-system line follows the same path as for any wet-system contamination: incoming supply, treatment plant and filtration integrity, storage vessel design and turnover, distribution loop temperature and residence time, dead legs and capped branches, the sanitisation regime and whether it reaches every part of the circuit, the connecting hose, and the machine's internal water path and rinse-water filter. Where chlorination or another residual disinfectant is relied upon, any recent reduction in dose or change in supply should be checked, since loss of residual has been linked to Bcc population expansion. The product line is specific to this organism and is at least as important: every in-use aqueous solution in the workflow should be identified, its container and refill practice examined, batch and lot numbers recorded, and samples taken from opened in-use containers and, where possible, from unopened stock of the same lot. Recovery from unopened stock indicates intrinsic contamination and requires product quarantine, supplier notification and reporting to the relevant regulator; recovery only from opened containers points to in-use contamination and to local practice.

A single isolate is sufficient to justify a full investigation, because the plausible sources are ones with wide reach. Escalation should include withdrawing the affected reprocessor from use pending investigation, quarantining any implicated product batch, and notifying infection prevention so that recent clinical isolates can be reviewed for a possible link. Where clinical Bcc isolates and an environmental or product isolate are both available, molecular typing is the step that converts an association into evidence, and polyclonal patient isolates should raise rather than lower suspicion of a common product vehicle. Verification of remediation should include repeat water sampling after sanitisation and, separately, sampling of replacement product containers under normal use conditions, since replacing the water without correcting the container practice will reproduce the problem.

Antimicrobial resistance

Burkholderia cepacia complex organisms are intrinsically resistant to numerous antimicrobial classes, including aminoglycosides, polymyxins and many beta-lactams, as a result of low outer membrane permeability, multidrug efflux systems, inducible beta-lactamases and modification of the lipopolysaccharide target for polymyxins. Therapeutic options are correspondingly limited and susceptibility testing is required to guide treatment. Intrinsic polymyxin resistance has a secondary diagnostic use, in that colistin-containing selective media are used to recover Bcc from mixed samples such as respiratory specimens from patients with cystic fibrosis.

Independently of antibiotic resistance, reduced susceptibility to antiseptics and preservatives is well documented and is the property most relevant to water systems and reprocessing chemistry. It is attributed to a combination of envelope impermeability, active efflux of biocide molecules, biofilm-mediated protection, and, in some isolates, catabolic degradation of the agent itself. Bcc has been recovered from in-use chlorhexidine preparations, benzalkonium chloride solutions, povidone-iodine and alcohol-free mouthwashes, which demonstrates that survival in a preserved or actively antiseptic aqueous product is an ordinary rather than an exceptional behaviour for this organism.

The operational implication is that the presence of a biocide in a solution is not evidence that the solution is free of Bcc, and that a chemical product implicated in an investigation should be sampled and cultured rather than presumed self-sterilising. It also means that remediation of a water system harbouring Bcc should not rely on a single chemical sanitisation. As with other biofilm-forming water organisms, chemical treatment suppresses but frequently does not eliminate the population, and physical measures such as removal of dead legs, replacement of compromised hoses, fittings and containers, and correction of stagnation are required for durable control.